Introduction
White matter of the central nervous system is made up of oligodendrocytes and these cells are responsible for the formation of myelin around axons [1] . It is very well documented that for neuronal homeostasis and effective conduction of nerve impulses, myelin sheath is required [2] . Oligodendrocytes mature during late embryonic development as oligodendrocyte precursor cells migrate and proliferate into oligodendrocytes [3, 4] .
Moreover studies suggest that approximately 8% of adult brain cells as OPCs remain immature. These OPCs are responsible for the repair of neuronal injury in white matter by promoting myelinated neurons [5] . Literature reveals that degeneration of neurons and loss of myelin sheath from the neurons occurs in demyelinating diseases that causes permanent disability [6] . In the early stage of demyelinating disease proliferation of OPCs occur due to endogenous repair mechanism, but if disease progresses to an advanced stage, this neuron repair gets altered [7] . Therefore, for the treatment of demyelinating disease, promotion of proliferation of OPCs is a good target for the development of drug.
However, recently natural compounds have gained attention in the management of neuronal injury. Caffeoylquinic acid was isolated from the Chinese herb Aster tataricus, which belongs to the family Asteraceae [8] .
It has been reported that caffeoylquinic acid is an ester of quinic and caffeic acid isolated from natural sources [9] . It has been reported to have anti-oxidant, anti-inflammatory, and anti-cancer activities [10] [11] [12] .
3,5-O-caffeoylquinic acid possesses strong anti-inflammatory activity, reducing the synthesis of cytokines, such as TNFα and IL-1β, and anti-oxidant properties [13] . Moreover, it reduces the generation of reactive oxygen species and, thus, reduces oxidative stress.
This report estimates the effect of CA against demyelinating diseases.
Material and methods

Animals
Female Wistar rats were kept individually under observation for delivery in the cage. All the rats were housed under a controlled condition specified as per guidelines. Abstract This report evaluates the protective effect of caffeoylquinic acid (CA) injury to oligodendrocyte precursor cells (OPCs) by promoting the formation of oligodendrocytes. Neonatal rat brain was used to isolate primary OPCs and non-lethal CoCl2 was used to induce hypoxic stress to inhibit the differentiation of OPCs. Differentiation of OPCs was estimated by survival assay and the expressions of myelin-basic-protein (MBP). Moreover, the effect of CA on the Akt signanling pathway was also estimated in the presence and absence of LY294002 (PI3K/Akt inhibitor) and adrenomedullin (AM) receptor antagonist (AM22-52) by using western blot assay. It was observed that CA enhances the differentiation OPCs in CoCl2 induced hypoxic stress condition. However treatment with CA in presence of LY294002 and AM22-52 was not able to enhance the differentiation of OPCs. Moreover treatment with CA significantly enhances the phosphorylation of Akt and presence of LY294002 and AM22-52 inhibits it. This report concludes that CA effectively attenuates the injury of white matter (OPCs) by enhancing the differentiation of OPCs. It enhances the formation of oligodendrocytes by activating AM receptor and thereby accelerates the regeneration of neuron in pathological condition. Adrenomedullin receptors are widely distributed in the brain and AM is reported to act as a neurohormone and neurotransmitter [14] . Literature has also suggested that neuronal injury can be protected by activating the AM receptor, and thereby effectively aiding in the management of certain CNS disorders [15, 16] . In addition, several reports reveal that neurogenesis can be achieved by activating the AM receptor and it also helps in maturation of OPCs [17] . CA is a natural product, reported Translational Neuroscience 
